Bone targeted alkaline phosphatase, kits and methods of use thereof

Details for Australian Patent Application No. 2008250945 (hide)

Owner Enobia Pharma Inc.

Inventors Boileau, Guy; Crine, Philippe; Leonard, Pierre; Heft, Robert; Lemire, Isabelle; Landy, Hal; Loisel, Thomas P.

Agent Cullens

Pub. Number AU-A-2008250945

PCT Pub. Number WO2008/138131

Priority 60/917,589 11.05.07 US

Filing date 12 May 2008

Wipo publication date 20 November 2008

International Classifications

C12N 15/55 (2006.01) Mutation or genetic engineering - Hydrolases (3)

A61K 38/46 (2006.01) Medicinal preparations containing peptides

A61P 19/08 (2006.01) Drugs for skeletal disorders

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 9/16 (2006.01) Enzymes, e.g. ligases (6.) - acting on ester bonds (3.1)

C12N 15/85 (2006.01) Mutation or genetic engineering - for animal cells

Event Publications

10 December 2009 PCT application entered the National Phase

  PCT publication WO2008/138131 Priority application(s): WO2008/138131

24 December 2009 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 18 Nov 2009

8 March 2012 Assignment before Grant

  Enobia Pharma Inc. The application has been assigned to Enobia Canada Limited Partnership

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008250951-Patient-specific surgical guidance tool and method of use

2008250931-A gas reformulation system comprising means to optimize the effectiveness of gas conversion